Description: Results of an SOA survey regarding the expectation for 2015 accruals for 3Rs and cost sharing reduction payments

Description: A commentary on whether or not the Illustrations Regulation has been successful.

Description: Revised pages for the RP-2000 Mortality Tables Report dated April 2000.

Description: Chapter 11 from the Models for Retirement Policy Analysis. PIMS is a microsimulation model that produces a distribution of PBGC’s exposure over a defined time interval. This chapter describes the major components of PIMS, the data types in PIMS, the PIMS simulation process, simulation activities, and current output.

Description: Chapter 9 of the Models for Retirement Policy Analysis. This chapter describes SSAIM, which is a policy simulation model of the Old Age and Survivors Insurance and Disability Insurance Social Security programs.

Description: The panel offers a summary of the Medicare Modernization Act signed into law in 2003, which implemented sweeping changes to the Medicare program. Topics include Medicare Advantage, the impact on Medicare Supplement, Part D, and the impact on retiree health plans. From Record of Society of Actuaries, Vol. 30, No. 3, Session 127

Description: 1988 Valuation Actuary Symposium. This session discussed the current thinking of the Special Advisory Committee on the Valuation Law which was formed by the NAIC to significantly expand the scope and usefulness of the proposed actuarial opinion.

Description: 1988 Valuation Actuary Symposium. The speakers in this session addressed the relative volatility of participating whole life versus universal life and the annual-premium versus single- premium basis.

Description: This paper attempts to quantify the benefits to the purchaser of a non-qualified variable annuity as compared to an investment in a mutual fund. From Actuarial Research Clearing House 1991, VOL. 3.

Description: HIV is still a big public health concern, but there are therapies available to prevent infection before and immediately after exposure. As legislatures and the USPSTF considers adding these therapies to the list of preventive care covered without cost share, actuaries will need to estimate the impact on their care cost. The presenters will share an actuarial tool kit to estimate the impact of covering PrEP and PEP for different populations. Examples are provided and discussion is welcome.